Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -54.27% is 19% above its 5-year average of -66.65%, near the high end of its 5-year range (-118.03%–-31.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.35% above its 12-month average of -68.13%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.27%.
RETURN ON EQUITY (ROE)
-54.27%
RETURN ON EQUITY (ROE) AVG TTM
-68.13%
RETURN ON EQUITY (ROE) AVG 3Y
-61.93%
RETURN ON EQUITY (ROE) AVG 5Y
-66.65%
RETURN ON EQUITY (ROE) AVG 10Y
-68.04%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.35%
CURRENT VS 3Y AVG
+12.37%
CURRENT VS 5Y AVG
+18.58%
CURRENT VS 10Y AVG
+20.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.89%
median of 684 covered companies
CURRENT VS SECTOR MEDIAN
-32.71%
vs the sector median at left
ProQR Therapeutics N.V.
Market Cap
$173.23M
Return on Equity (ROE)
-54.27%
TTM Avg
-68.13%
3Y Avg
-61.93%
5Y Avg
-66.65%
Market Cap
$172.81M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$172.53M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$175.39M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
Market Cap
$170.49M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
Market Cap
$176.55M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$176.97M
Return on Equity (ROE)
-84.80%
TTM Avg
-85.93%
3Y Avg
-69.58%
5Y Avg
-185.12%
Market Cap
$169.76M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$169.56M
Return on Equity (ROE)
-47.36%
TTM Avg
-30.00%
3Y Avg
-33.39%
5Y Avg
-32.72%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.23M | -54.27% | -68.13% | -61.93% | -66.65% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.81M | -116.42% | -18.43% | -136.68% | -137.61% |
| Cue Biopharma, Inc. (CUE)vs › | $172.53M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.39M | -44.23% | -36.61% | -30.86% | -42.66% |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | -31.32% | 4.38% | 4.09% | 11.26% |
| Journey Medical Corporation (DERM)vs › | $176.55M | -19.01% | -54.50% | -75.60% | -59.28% |
| Yarrow Bioscience Inc (YARW)vs › | $176.97M | -84.80% | -85.93% | -69.58% | -185.12% |
| MediWound Ltd. (MDWD)vs › | $169.76M | -56.61% | -75.88% | -88.15% | -30.55% |
| Nkarta, Inc. (NKTX)vs › | $169.56M | -47.36% | -30.00% | -33.39% | -32.72% |
| OptimizeRx Corp. (OPRX)vs › | $166.07M | 3.51% | -6.60% | -9.04% | -6.71% |
ROE
-54.3%
ROA
-32.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -54.27% |
| 2026-03-31 | -106.82% |
| 2025-12-31 | -71.42% |
| 2025-09-30 | -60.76% |
| 2025-06-30 | -47.39% |
| 2025-03-31 | -35.19% |
| 2024-12-31 | -31.39% |
| 2024-09-30 | -84.48% |
| 2024-06-30 | -61.61% |
| 2024-03-31 | -71.65% |
| 2023-12-31 | -60.43% |
| 2023-09-30 | -74.54% |
| 2023-06-30 | -90.01% |
| 2023-03-31 | -87.94% |
| 2022-12-31 | -87.56% |
| 2022-09-30 | -118.03% |
| 2022-06-30 | -71.15% |
| 2022-03-31 | -58.35% |
| 2021-12-31 | -48.60% |
| 2021-09-30 | -38.85% |
| 2021-06-30 | -39.17% |
| 2021-03-31 | -74.38% |
| 2020-12-31 | -63.19% |
| 2020-09-30 | -62.11% |
| 2020-06-30 | -55.77% |
| 2020-03-31 | -65.59% |
| 2019-12-31 | -53.15% |
| 2019-09-30 | -80.37% |
| 2019-06-30 | -55.61% |
| 2019-03-31 | -45.20% |
| 2018-12-31 | -35.73% |
| 2018-09-30 | -30.50% |
| 2018-06-30 | -152.82% |
| 2018-03-31 | -116.29% |
| 2017-12-31 | -88.30% |
| 2017-09-30 | -118.48% |
| 2017-06-30 | -106.66% |
| 2017-03-31 | -87.98% |
| 2016-12-31 | -77.51% |
| 2016-09-30 | -58.96% |
| 2016-06-30 | -46.17% |
| 2016-03-31 | -38.28% |
| 2015-12-31 | -23.65% |
| 2015-09-30 | -17.67% |
| 2015-06-30 | -14.20% |
| 2015-03-31 | -11.05% |
| 2014-12-31 | -12.04% |
| 2014-09-30 | -11.20% |
| 2014-06-30 | -27.15% |
